Newly Diagnosed Clinical Trials in Suzhou, Jiangsu
6 recruitingSuzhou, Jiangsu, China
Showing 1–6 of 6 trials
Recruiting
Phase 1
Safety and Efficacy of RN1201 Injection as First-Line Treatment for Newly Diagnosed Multiple Myeloma
Newly Diagnosed Multiple Myeloma (NDMM)Multiple Myloma
The First Affiliated Hospital of Soochow University18 enrolled1 locationNCT07652138
Recruiting
Phase 2
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
Newly Diagnosed Acute Myeloid Leukemia (AML)Intensive Chemotherapy UnfitAge ≥60
First Affiliated Hospital of Zhejiang University25 enrolled5 locationsNCT07172204
Recruiting
Phase 2
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
Acute Myeloid Leukemia, AdultNewly Diagnosed
The First Affiliated Hospital of Soochow University172 enrolled1 locationNCT06532552
Recruiting
Phase 2
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
Newly DiagnosedAcute Monocytic Leukemia
The First Affiliated Hospital of Soochow University92 enrolled1 locationNCT05566054
Recruiting
Phase 4
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
MRDMultiple MyelomaHigh-Risk+1 more
The First Affiliated Hospital of Soochow University59 enrolled1 locationNCT06409702
Recruiting
Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients
Newly Diagnosed Multiple Myeloma
The First Affiliated Hospital of Soochow University50 enrolled1 locationNCT06682156